Mustgrow Biologics Corp Stock Price, News & Analysis

MustGrow Biologics (OTCQB: MGROF) has announced a proposed non-brokered private placement to raise approximately $2 million, with an option to increase by an additional $1 million. The placement consists of Units priced at $1,000 each, comprising convertible debentures and warrants. The debentures are convertible to common shares at $1.50 per share and carry an 8% annual interest rate. Each Unit includes 666 warrants exercisable at $1.90 per share.

The company plans to close the placement around January 10, 2025. Proceeds will be used for TerraSante™ inventory production, working capital, and general corporate purposes. The securities will have a four-month hold period and require TSX Venture Exchange approval.

MustGrow Biologics has signed a non-binding term sheet with Univar Solutions Canada to acquire NexusBioAg. The strategic acquisition, targeted to close by December 31, 2024, includes deferred cash payment and contingent payments in 2025 and 2026. The deal would position MustGrow as a fully integrated provider of biological and regenerative agriculture solutions in Canada. NexusBioAg's sales and marketing team would bring extensive experience and industry networks to drive growth. The integration would give MustGrow access to NexusBioAg's existing sales, with new third-party product lines planned for 2025 and MustGrow's proprietary TerraMG™ launching thereafter.

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) has provided its 2024 pipeline update, marking a significant transition from R&D to commercialization. Key highlights include:

1. TerraSante™ biofertility product: Initial sales have commenced in key U.S. states, with potential for full-scale sales ramp-up in 2025 and 2026.

2. TerraMG™ soil biopesticide: Commercialization is progressing under the Bayer agreement for Europe, Middle East, and Africa. Registration work continues in the U.S. and Canada.

3. Intellectual property portfolio has grown to 112 issued and pending patents.

4. Expiration of exclusive non-commercial agreements with NexusBioAg, Janssen PMP, and Sumitomo

The company is focusing on delivering commercialization of its products, validating efficacy through sales, and driving global expansion.

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) has secured funding from Agriculture and Agri-Food Canada (AAFC) to explore mustard-derived ingredient opportunities in human and animal health applications. The project, conducted at AAFC's Guelph Research & Development Centre, will investigate potential uses in:

• Functional foods and nutraceuticals for improved immunity and gut health
• Natural food preservatives
• Antibiotic replacements in animal feeds

The research aims to analyze bioactive components in mustard seed for antibiotic and gut health applications, assess their efficacy against food spoilage microbes and disease pathogens, and test their antioxidant and anti-inflammatory effects. This initiative aligns with global efforts to combat antimicrobial resistance, a significant threat to human and animal health.

MustGrow has received approval from the Florida Department of Agriculture to commence sales of TerraSanteTM, an organic biofertility product in Florida. TerraSanteTM aims to enhance soil health, nutrient efficiency, and plant yields.

This registration includes the Organic OMRI Listed® certification, already held in Arizona, Idaho, Oregon, and Washington State. Florida's agriculture spans 47,300 farms and 9.7 million acres, producing a significant array of crops. MustGrow aims for further state-level registrations in the U.S.

TerraSanteTM contains plant proteins and carbohydrates, targeting soil and soil microbiome health, potentially improving nutrient availability, plant vigor, and yields with no artificial additives.

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) has announced the grant of 1,575,398 deferred share units (DSUs) and restricted share units (RSUs) to certain directors, officers, and consultants, effective September 3, 2024. This grant is made under the company's Omnibus Equity Incentive Plan. The DSUs will vest when the holder ceases to be a director, officer, or employee of MustGrow or its affiliates. Upon settlement, each DSU will entitle the holder to receive one common share in the company's capital or an equivalent cash payment, at MustGrow's discretion.

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) has received Arizona Department of Agriculture approval to sell TerraSante™, an organic biofertility product, in Arizona. This registration complements existing certifications in Idaho, Oregon, and Washington State. TerraSante™, derived from mustard plants, aims to enhance soil health, nutrient efficiency, and crop yields.

Arizona, with over 25 million acres of farmland, produced US$3.0 billion in agricultural crops in 2022, led by vegetables, melons, and potatoes at US$1.43 billion. The state ranks 2nd in the U.S. for various produce, including lettuce and broccoli. MustGrow's expansion into Arizona is strategic, considering many California agriculture companies use Arizona for winter farming.

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) has received approval from the Idaho State Department of Agriculture to sell TerraSante™, an organic biofertility product, in Idaho. This registration includes organic certification under MustGrow's existing Organic OMRI Listed® certifications in Oregon and Washington State.

TerraSante™ is a mustard plant-based technology focused on improving soil and soil microbiome health, nutrient and water use efficiencies, and plant yields. It contains nutritious plant proteins and carbohydrates that feed the soil and soil microbes, potentially enhancing beneficial microbial activity and promoting long-term sustainable soil health.

Idaho is a significant agricultural state, ranking #1 in the U.S. for potatoes, barley, alfalfa hay, peppermint oil, and food trout production. The state's total agricultural crop production in 2021 was valued at US$3.3 billion, with potatoes being the top crop at US$1.3 billion in 2023.

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) is set to promote its organic biofertility product TerraSante at the Cal Poly Strawberry Field Day on August 8, 2024. This event attracts hundreds of strawberry growers, researchers, and industry representatives from California, where strawberries represent a US$2.68 billion annual production business.

To accelerate sales efforts, MustGrow has engaged Michael Atkins, a 17-year Nutrien sales veteran and agronomist with extensive experience in Coastal California. The company recently received California Department of Food Agriculture registration approval and organic certification for TerraSante, complementing its existing certifications in Oregon and Washington State.

TerraSante focuses on soil microbiome health, nutrient and water use efficiencies, and plant yields. As an organic biofertilizer, it contains plant proteins and carbohydrates that feed soil microbes, potentially improving nutrient availability and crop performance.